Navigation Links
Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results
Date:2/9/2009

BETHESDA, Md., Feb. 9 /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the third quarter of fiscal year 2009.

Revenue in the third quarter of fiscal year 2009 increased 16% to $41.6 million from $36.0 million in the third quarter of fiscal year 2008. Revenue from the healthcare services division increased 16% to $20.5 million from $17.7 million in the third quarter of fiscal year 2008, and revenue from the medical products division increased 15% to $21.1 million from $18.3 million in the prior year period. Revenue performance reflects growth in inpatient and outpatient revenues in the hospital division and increasing demand for medical equipment products and services, partially offset by delays in openings of new clinics in Shanghai and Guangzhou as well as the delay until the fourth quarter in the recognition of revenue for certain medical equipment shipped as part of a development bank equipment supply contract.

During the quarter, the Company recorded income from operations of $1.9 million, compared to income from operations of $3.9 million in the same quarter last year. Total operating costs and expenses for the third quarter of fiscal year 2009 increased 24% to $39.7 million as compared with $32.1 million in the prior period. Increased operating costs reflect $662,000 of development and startup expenses for new clinics, as well as costs for the renewal of multi-year physician contracts, additional medical personnel in our Beijing and Shanghai hospitals, increased direct patient care costs and increased medical products selling activities.

Roberta Lipson, President and CEO of Chindex, commented, "We made substantial progress this quarter in our KfW and U.S. Export-Import Bank contracts and remain confident that we can complete deliveries of the remaining $18.4 million by the end of this fiscal year. We are also keeping a close eye on the healthcare reform in China and continue to believe that Chindex is well positioned to benefit from these efforts over the long term."

As previously disclosed, in October 2008, the Company redeemed variable- return CDs and reinvested the funds in traditional deposits with guaranteed returns, given the unfavorable economic outlook. This change was made to minimize the effect of the significant disruptions in the world financial and credit markets. In connection with this, the Company recognized a pretax expense of $653,000, or $0.03 per diluted share, reflecting the early redemption of the CDs and related write offs and tax benefit.

The Company recorded a $658,000 provision for taxes, or an effective tax rate of 43.7%, in the three months ended December 31, 2008 as compared to a provision for taxes of $76,000, or an effective tax rate of 1.9%, for the three months ended December 31, 2007. The current period tax expense includes the negative effect of losses in entities for which Chindex cannot recognize a benefit in accordance with SFAS 109, "Accounting for Income Taxes." The Company's effective tax rate was low in the prior year period due to an increase in its net deferred tax assets resulting from an increase in the projected profitability in future periods of entities in the U.S. and China.

Net income for the quarter ended December 31, 2008 was $846,000, or $0.05 per diluted share. This compares to net income of $3.9 million, or $0.28 per diluted share, for the quarter ended December 31, 2007.

Net income in the third quarter of fiscal 2009 includes $662,000 of expenses, or $0.03 per diluted share, related to development expenses for expansion of the United Family Healthcare network, as well as $653,000, or $0.03 per diluted share, in connection with variable-return CDs described above.

Medical Products division business results:

For the third quarter of fiscal year 2009, revenue increased 15% to $21.1 million from $18.3 million in the prior year quarter. As of December 31, 2008, deferred revenue increased to $3.8 million, which mainly reflects $2.4 million of deferred revenue recorded in the fiscal third quarter of 2009 related to the execution of one of the KfW Development Bank contracts.

Gross profit for the Medical Products division increased to $5.6 million from $5.2 million in the prior year's third quarter, representing a decrease in gross profit margin to 26% from 28% in the year over year period. A 2% variance in gross profit margin is in line with historical averages.

Selling, marketing, general and administrative expenses for the Medical Products division increased 24% to $6.2 million from $5.0 million in the third quarter of the prior year. Increased expenses during the period were a result of increased selling activity in advance of expected sales increases.

Lipson added, "Our Medical Products division continues to be well positioned to capitalize on the increased need for high end, high margin medical products in China. We approach this division with a long-term view. While our costs did not increase substantially in this division versus the second quarter of fiscal 2009, results were impacted by timing of revenue recognition."

Healthcare Services division business results:

For the third quarter of fiscal year 2009, revenue increased 16% to $20.5 million from $17.7 million for the prior year quarter. The increase in revenue is attributable to growth in both inpatient and outpatient revenues provided in the Beijing and Shanghai markets, but which was less than expected.

During the period, operating costs increased by 27% to $18.4 million from $14.5 million in the prior year quarter. The increase in costs was primarily due to an increase in salary expense, resulting from the renegotiation of multi-year physician contracts and the ramp-up in the number of personnel needed to meet the increasing demand for services in Beijing and Shanghai, as well as development and post-opening operating expenses related to the new clinic in Guangzhou, the pending clinic in Shanghai as well as increased direct patient care costs, costs allocated from the parent company and higher excise taxes.

Fiscal 2009 Outlook:

Lipson stated, "We continue to expect Medical Products revenue of $50-$55 million for the second half of fiscal 2009, as we should see considerable product shipments in the fourth quarter. For Healthcare Services, we anticipate that our full year revenue growth should be in the mid-twenty percent range. We are adjusting our growth rate expectation to account for the delay in opening the Shanghai Pudong Clinic and the later than expected start up of our Guangzhou clinic."

"Demand for our products and services remains strong and we have not seen an impact as a result of the world-wide financial crisis. Given the policies implemented by China in response to the crisis, we are optimistic that our business growth opportunities will not be substantially impacted by the current situation."

Fiscal 2009 Third Quarter Conference Call

Management will host a conference call today at 8:00 am ET to discuss financial results.

To participate in the conference call, international callers dial +1-719- 325-4757 and domestic callers dial 1-877-874-1568 approximately 10 minutes before the conference call is scheduled to begin.

The telephone replay will be available on the day of the call at (international) +1-719-457-0820 and (domestic) 1-888-203-1112 and continue to be available through February 23, 2009.

This call is also being webcast and will be accessible at Chindex's website http://ir.chindex.com/events.cfm . The event will be archived and available for replay through February 23, 2009.

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. Healthcare services are provided through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in Beijing, Shanghai, Guangzhou and Wuxi. The Company sells medical products manufactured by various major multinational companies, including Siemens AG and Intuitive Surgical, for which the Company is the exclusive distribution partner for the sale and servicing of color ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-seven years of experience, approximately 1,200 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, http://www.chindex.com and http://www.unitedfamilyhospitals.com .

Safe Harbor Statement

Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in our annual report on Form 10-K for the year ended March 31, 2008, updates and additions to those "Risk Factors" in our interim reports on Form 10-Q, Forms 8-K and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue" or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We have no obligation to update these forward- looking statements.




                         CHINDEX INTERNATIONAL, INC.
                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                 (in thousands except share and per share data)
                               (Unaudited)

                                 Three months ended      Nine months ended
                                    December 31,            December 31,
                                     2008        2007        2008        2007
    Product sales                 $21,070     $18,316     $52,607     $47,079
    Healthcare services
     revenue                       20,530      17,695      59,171      48,355
    Total revenue                  41,600      36,011     111,778      95,434

    Cost and expenses
     Product sales costs           15,493      13,131      38,576      34,417
     Healthcare services costs     17,185      13,724      49,586      37,693
     Selling and marketing
      expenses                      3,867       3,153       9,590       8,619
     General and administrative
      expenses                      3,158       2,069       9,728       6,792
    Income  from operations         1,897       3,934       4,298       7,913
    Other (expenses) and
      income
      Interest expense               (259)       (198)       (738)       (573)
      Interest income                 527         358       1,316         500
      Miscellaneous income
      (expense) - net                (661)       (124)     (1,257)       (171)
    Income before income taxes      1,504       3,970       3,619       7,669
    Provision for income taxes       (658)        (76)     (2,073)     (1,328)
    Net income                       $846      $3,894      $1,546      $6,341

    Net income per common
     share - basic
     Net income                     $0.06       $0.34       $0.11       $0.57
    Weighted average shares
     outstanding - basic       14,455,237  11,583,911  14,395,239  11,195,153

    Net income per common
     share - diluted
     Net income                     $0.05       $0.28       $0.10       $0.49
    Weighted average shares
     outstanding - diluted     15,836,521  14,126,348  16,089,705  13,037,838



                           CHINDEX INTERNATIONAL, INC.
                      CONSOLIDATED CONDENSED BALANCE SHEETS
                        (in thousands except share data)


                                         December 31, 2008    March 31, 2008
                                                (Unaudited)
                   ASSETS
    Current assets:
    Cash and cash equivalents                      $21,669           $79,258
    Restricted cash                                  1,979             1,123
    Investments                                     14,055                 0
    Trade accounts receivable, less
     allowance for doubtful accounts of
    $4,605 and $3,940, respectively
      Product sales receivables                     16,635            12,098
      Patient service receivables                    9,103             9,085
    Inventories, net                                 8,117             9,796
    Deferred income taxes                            2,037             1,656
    Other current assets                             6,212             3,294
      Total current assets                          79,807           116,310
    Investments                                     39,144                 0
    Restricted cash                                    818                 0
    Property and equipment, net                     20,510            18,428
    Noncurrent deferred income taxes                   104                 0
    Other assets                                     1,758             1,241
      Total assets                                $142,141          $135,979
    LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
    Short-term debt, current portion of
     long-term debt and vendor financing              $970               $82
    Current portion of capitalized leases               31                36
    Accounts payable                                 8,016             9,938
    Accrued expenses                                10,481            11,064
    Other current liabilities                        3,371             3,571
    Deferred revenue                                 3,781               765
    Income taxes payable                               518               349
    Total current liabilities                       27,168            25,805
    Long-term debt, vendor financing and
     convertible debentures                         22,930            22,556
    Long-term portion of capitalized
     leases                                              0                22
    Long-term deferred tax liability                     0               208
      Total liabilities                             50,098            48,591
    Commitments and contingencies
    Stockholders' equity:
       Preferred stock, $.01 par value,
        500,000 shares authorized, none
        issued                                           0                 0
       Common stock, $.01 par value,
        28,200,000 shares authorized,
        including
       3,200,000 designated Class B:
    Common stock - 13,452,007  and
     13,074,593 shares issued and
     outstanding at December 31, 2008 and
     March 31, 2008, respectively                      135               131
    Class B stock - 1,162,500 shares
     issued and outstanding at December
     31, 2008 and March 31, 2008,
     respectively                                       12                12
       Additional paid in capital                   94,960            92,586
    Accumulated other comprehensive
     income                                          2,941             2,210
    Accumulated deficit                             (6,005)           (7,551)
    Total stockholders' equity                      92,043            87,388
    Total liabilities and stockholders'
     equity                                       $142,141          $135,979




                           CHINDEX INTERNATIONAL, INC.
                               SEGMENT INFORMATION

The Company operates in two businesses: Healthcare Services and Medical Products. The Company evaluates performance and allocates resources based on profit or loss from operations before income taxes, not including foreign exchange gains or losses. The following segment information has been provided per Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information:" (in thousands except share data)

                                         Healthcare     Medical
                                           Services    Products         Total
    For the three months ended December
     31, 2008:
    Sales and service revenue                $20,530     $21,070      $41,600
    Gross Profit                                n/a *      5,577          n/a
    Gross Profit %                              n/a *        26%          n/a
    Income (loss) from operations before
     foreign exchange                         $2,142       $(630)      $1,512
    Foreign exchange gain                                                 385
    Income from operations                                             $1,897
    Other (expense), net                                                 (393)
    Income before income taxes                                         $1,504
    As of December 31, 2008:
    Assets                                   $95,984     $46,157     $142,141


                                          Healthcare     Medical
                                            Services    Products        Total
    For the three months ended December
     31, 2007:
    Sales and service revenue                $17,695     $18,316      $36,011
    Gross Profit                                n/a *      5,185          n/a
    Gross Profit %                              n/a *        28%          n/a
    Income from operations before foreign
     exchange                                 $3,220        $197       $3,417
    Foreign exchange gain                                                 517
    Income from operations                                             $3,934
    Other(expense), net                                                    36
    Income before income taxes                                         $3,970
    As of March 31, 2008:
    Assets                                   $93,727     $42,252     $135,979


                                          Healthcare     Medical
                                            Services    Products        Total
    For the nine months ended December
     31, 2008:
    Sales and service revenue                $59,171     $52,607     $111,778
    Gross Profit                                n/a *     14,031          n/a
    Gross Profit %                              n/a *        27%          n/a
    Income (loss) from operations before
     foreign exchange                         $5,970     $(2,185)      $3,785
    Foreign exchange gain                                                 513
    Income from operations                                             $4,298
    Other (expense), net                                                 (679)
    Income before income taxes                                         $3,619
    As of December 31, 2008:
    Assets                                   $95,984     $46,157     $142,141




                                          Healthcare     Medical
                                            Services    Products        Total
    For the nine months ended December
     31, 2007:
    Sales and service revenue                $48,355     $47,079      $95,434
    Gross Profit                                n/a *     12,662          n/a
    Gross Profit %                              n/a *        27%          n/a
    Income (loss) from operations before
     foreign exchange                         $8,057     $(1,003)      $7,054
    Foreign exchange gain                                                 859
    Income from operations                                             $7,913
    Other (expense), net                                                 (244)
    Income before income taxes                                         $7,669
    As of March 31, 2008:
    Assets                                   $93,727     $42,252     $135,979

    * Gross profit margins are not routinely calculated in the healthcare
      industry.

    For more information, please contact:

     Integrated Corporate Relations
     Ashley M. Ammon
     Tel: +1-203-682-8200

'/>"/>
SOURCE Chindex International, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Chindex International, Inc. to Participate in UBS Global Healthcare Services Conference
2. Chindex International, Inc. to Report Fiscal Third Quarter 2009 Financial Results
3. Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference
4. Chindex International, Inc. Adopts Voluntary Executive Compensation Restrictions
5. Chindex International Inc. Reports Second Quarter FY 2009 Financial Results
6. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
7. Chindex International, Inc. Announces Appearances at Additional November Conferences
8. Chindex International to Report Fiscal 2009 First Quarter Financial Results
9. Chindex International, Inc. Announces CDC Contract Signing
10. Chindexs United Family Healthcare Launches ChinaHealthWatch.org - A global resource for travelers to China
11. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology: